Key Market Indicators
Icelander hypno-sedative medicine sales are expected to reach $6.85 million by 2026. This figure is up from $6.05 million in 2021, representing an average growth rate of 2.4% year-on-year. Since 1994, the Icelander market has seen an average annual growth of 9.2%. In 2021, the country ranked 18th; Slovakia was ahead with $6.05 million in sales. Germany, Sweden and Belgium came in second, third and fourth place respectively.
